Please assess the completion status of the following clinical trial:

Trial Title: Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* cemented application of components~* bilateral subjects randomized by knee~* patients with pre-existing contralateral knee surgery~* painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis, or traumatic arthritis where one or more compartments are involved~* correction of varus, valgus, or posttraumatic deformity~* sufficient soft tissue surrounding the knee, including the Anterior Cruciate Ligament~Exclusion Criteria:~* cementless application of components~* BMI greater than or equal to 40~* use of Anterior Stabilized Bearings~* patients with severe pre-operative varus or valgus deformity greater than or equal to 15 degrees~* correction or revision of previous joint replacement procedure on index knee~* infection~* sepsis~* osteomyelitis~Relative exclusion criteria:~* uncooperative patient or patient with neurological disorders who is incapable of following directions~* osteoporosis~* metabolic disorders which may impair bone formation~* osteomalacia~* distant foci of infections which may spread to the implant site~* rapid joint destruction, marked bone loss, or bone resorption apparent on roentgenogram~* vascular insufficiency, muscular atrophy, neuromuscular disease~* incomplete or deficient soft tissue surrounding the knee, including the anterior cruciate ligament

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Vanguard XP Bicruciate Knee System (Type: EXPERIMENTAL): 153 patients receive Vanguard XP Bicruciate Knee System
- Vanguard CR Knee System (Type: ACTIVE_COMPARATOR): 153 patients receive Vanguard CR Knee System

Based on this trial design, predict the completion outcome and termination type (if applicable).